Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1639.30
7.65 (0.47%)
< Home < Back

USFDA completes inspection at Sun Pharma’s Halol plant in Gujarat

Date: 08-09-2018

US Food and Drug Administration (USFDA) has inspected Sun Pharmaceutical Industries Halol plant in the state of Gujarat between August 27-31, 2018. After the inspection, USFDA has issued six observations.

The unit manufactures pretty much every formulation including tablets, capsules, liquids, sterile dry powder injectable, small volume injectable, ointments, soft gelatine caps andaerosols, among others.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.